Home > Chemicals & Materials > Surfactants > Biodegradable Surfactants > Biosurfactants Market

Biosurfactants Market Analysis

Report ID: GMI484
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Biosurfactants Market Analysis

Global Rhamnolipids Biosurfactants Market By Revenue

The rhamnolipids biosurfactants market is poised to be worth over USD 3 billion by 2032. Rhamnolipids are extensively utilized across the pharmaceutical and therapeutics industries owing to their low toxicity and capability to inhibit the growth of several human cancer cell lines. Moreover, the expanding product applications in personal care products due to its increased solubility and good foaming & wetting tendencies have led to of the use of rhamnolipids in cosmetic industry.

Rhamnolipids are used in healthcare products in different formulations including antacids, acne pads, anti-dandruff products, and contact lens solution. Rhamnolipids are effective in wound healing, treatments, preventing gum diseases, and averting antimicrobial & antiviral activities. These factors are anticipated to drive the rhamnolipids demand in pharmaceutical applications and subsequently stimulate market expansion.

Global Sophorolipids Biosurfactants from Personal Care Application

Learn more about the key segments shaping this market

Download Free Sample

The sophorolipids biosurfactants market from personal care application segment was worth over USD 720 million in 2022 and is expected to witness around 7.5% CAGR through 2032. Sophorolipids are widely used as foaming agents, emulsifiers, wetting agents, solubilizers, and active ingredients in several cosmetic formulations. The tremendous uptick in demand for personal care and cosmetic products driven by the increasing expenditure on beauty and aesthetics will bring about lucrative gains to the bio based surfactants industry.

North America Mannosylerythritol Lipid Biosurfactants Market By Revenue

Looking for region specific data?

Download Free Sample

North America biosurfactants market from mannosylerythritol products is projected to amass more than USD 1 billion by 2032. Mannosylerythritol Lipids (MEL) have antimicrobial properties, hence are used for manufacturing face masks, face wash, and other skin care products. The regional growth can be credited to the rising disposable incomes and the increasing sales of cosmetics and personal care products. Besides, the growing awareness about mental health coupled with the proven effectiveness of mannosylerythritol lipids in treating schizophrenia and other diseases caused by microbial infections and dopamine metabolic dysfunction will fuel the regional industry landscape. Asia Pacific Biosurfactants industry is estimated to grow at over 5.5% CAGR in the coming years owing to widening applications and ecofriendly aspects.

Authors: Kunal Ahuja, Sarita Bayas

Frequently Asked Questions (FAQ) :

Global market size for biosurfactant was worth more than USD 8 billion in 2022 and is expected to witness around 5% CAGR from 2023 to 2032 driven by surging healthcare spending and the flourishing pharmaceutical sector.

Rhamnolipids segment is anticipated to garner over USD 3 billion by 2032 owing to the increasing utilization of rhamnolipids biosurfactants in pharmaceuticals, agricultural, and food processing applications.

Sophorolipids biosurfactants from personal care application segment is poised to expand at around 7.5% CAGR through 2032, attributed to the rising income levels and increased spending on beauty and aesthetics.

Leading enterprises participating in the biosurfactants market include BASF SE, Merck KGaA, Evonik Industries AG, Givaudan SA, Kao Corporation, and Boruta Zachem SA.